| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |